Table 2.
Stratum | Detectable first viral load (dVL)a |
Suppressed first viral load (sVL)a |
||
---|---|---|---|---|
Service use cluster | Sporadic care | Frequent use | Sporadic care | Frequent use |
Risk ratio (95 % CI) | Risk ratio (95 % CI) | |||
Race/gender group | ||||
White male | (Reference) | (Reference) | (Reference) | (Reference) |
White female | 0.94 (0.42, 2.08) | 3.32 (1.17, 9.42) | 1.21 (0.59, 2.51) | 2.27 (0.49, 10.57) |
Non-white male | 1.09 (0.74, 1.61) | 1.34 (0.66, 2.72) | 1.49 (0.99, 2.22) | 0.77 (030, 1.99) |
Non-white female | 1.18 (0.76, 1.85) | 2.85 (1.36, 5.97) | 1.20 (0.77, 1.88) | 0.52 (0.16, 1.74) |
Insurance status | ||||
Self-pay | (Reference) | (Reference) | (Reference) | (Reference) |
Private | 0.69 (0.47, 1.01) | 0.98 (0.52, 1.84) | 1.00 (0.64, 1.56) | 0.17 (0.03, 0.77) |
Public | 0.72 (0.50, 1.03) | 1.17 (0.68, 2.02) | 0.91 (0.60, 1.39) | 0.72 (0.28, 1.88) |
County of residence | ||||
Primary | (Reference) | (Reference) | (Reference) | (Reference) |
Secondary | 1.14 (0.80, 1.60) | 0.78 (0.47, 1.29) | 1.13 (0.77, 1.65) | 1.60 (0.57, 4.48) |
Outer | 1.18 (0.77, 1.81) | 0.67 (0.34, 1.31) | 1.02 (0.65, 1.62) | 1.23 (0.34, 4.45) |
Out of state | 2.53 (1.03, 6.21) | 0.51 (0.06, 4.18) | 1.27 (0.41, 3.98) | 12.63 (1.85, 86.2) |
Age at entry (for each additional 10 years) | 1.00 (1.00, 1.00) | 100 (1.00, 1.00) | 1.00 (1.00, 1.00) | 1.00 (1.00, 101) |
Attended first year visits (for each additional 1 visit) | 0.84 (0.78, 0.91) | 112 (1.04, 1.21) | 0.72 (0.64, 0.81) | 1.61 (1.33, 1.94) |
Missed visits first year (for each additional 10 % visits missed) | 1.00 (1.00, 1.00) | 1.00 (1.00, 1.00) | 1.00 (1.00, 1.00) | 1.00 (1.00, 1.00) |
VL suppressed first year (for each additional 10 % suppressed) | 0.98 (0.93, 1.04) | 0.88 (0.81, 0.95) | 0.95 (0.87, 1.04) | 0.92 (0.75, 1.13) |
CD4 ≥ 350 first year (each additional 10 % above 350) | 1.00 (0.96, 1.03) | 0.93 (0.88, 0.99) | 0.99 (0.94, 1.03) | 1.02 (0.92, 1.14) |
Detectable or suppressed first viral load (dVL, sVL) are categorized using a cut-point of ≥400 copies/mL or <400 copies/mL, respectively